AI C3.ai, Inc.

NYSE
$10.46

C3.ai's First Quarter Under Siebel Tests Whether the Bleeding Has Stopped

C3.ai heads into this report carrying the weight of four consecutive quarters of eroding revenue, a leadership shakeup, and a founder-CEO who has staked his own money and reputation on turning things around. The question now is not whether the company can grow again but whether it can simply stabilize. Wall Street is not expecting much on that front. Consensus calls for revenue of $51.5 million, down nearly 27% from a year ago, alongside a non-GAAP loss of 25 cents a share. The Earnings Whisper number sits a penny below consensus at a 26-cent loss, a modest gap that suggests expectations have already been pulled down close to the floor rather than signaling any dramatic shift in sentiment.

Management's own guidance framed this quarter as flat to slightly up sequentially, with revenue expected between $50 million and $54 million, so consensus sits comfortably in the middle of that range. That is a low bar by design. The bigger number to watch is the fiscal 2027 outlook of $210 million to $240 million, which implies the company still expects revenue to shrink from this year's roughly $235 million pace before any recovery takes hold. That guidance, delivered alongside Tom Siebel's return as CEO, was less a growth plan than a damage-control framework, and this quarter is the first real test of whether the damage is actually being contained.

The prior call was defined by a stark divergence between cost discipline and demand deterioration. Siebel moved fast on expenses, expanding a $135 million savings program, cutting headcount by roughly 35%, and guiding opex down more than $30 million year over year. Investors should expect confirmation that opex lands near or below the $96.5 million target, since execution on cost has been the one area management has actually delivered on. But the more important signals sit above the expense line. Bookings were not even disclosed last quarter after falling from $86.4 million to $46.9 million over two prior periods, and IPD signings have collapsed from 28 to just 9 per quarter. Gross margin has been stuck at 37% for two straight quarters after sitting above 50% only six months earlier. Any further slippage in these areas would undercut management's insistence that the problem is sales execution rather than demand or competitive share loss.

Sentiment heading into this report has improved somewhat, with bearish readings easing to 10.5% from nearly 32% last quarter, suggesting investors are less braced for a negative surprise than they were three months ago. Yet the stock itself has not reflected that calm. Shares are down almost 10% since the last report while the S&P 500 rose, underperforming the market by more than 11 points. Trading below its 200-day moving average of $10.86 and sitting well off the post-earnings high of $11.36, the stock reflects a market still waiting for tangible proof rather than pricing in a turnaround already underway.

The real test for this report is whether the operational metrics that matter most, bookings, active IPD counts, and gross margin, show any sign of bottoming rather than continuing their multi-quarter slide. Cost cuts can only carry the story so far before investors need evidence that the new go-to-market structure and expanded account targeting are translating into actual demand. If those figures stabilize even modestly, it would mark the first sign that Siebel's reset is gaining traction. If they keep falling, the narrative of a controlled turnaround will look increasingly difficult to defend.

← Back to AI news